Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions RS McIntyre, DS Cha, JK Soczynska, HO Woldeyohannes, LA Gallaugher, ... Depression and anxiety 30 (6), 515-527, 2013 | 938 | 2013 |
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions RS McIntyre, M Alsuwaidan, BT Baune, M Berk, K Demyttenaere, ... World Psychiatry 22 (3), 394-412, 2023 | 267 | 2023 |
Bipolar disorder and metabolic syndrome: an international perspective RS McIntyre, M Danilewitz, SS Liauw, DE Kemp, HTT Nguyen, LS Kahn, ... Journal of affective disorders 126 (3), 366-387, 2010 | 266 | 2010 |
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus JK Soczynska, SH Kennedy, HO Woldeyohannes, SS Liauw, ... Neuromolecular medicine 13, 93-116, 2011 | 201 | 2011 |
The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project RS McIntyre, JZ Soczynska, HO Woldeyohannes, MT Alsuwaidan, ... Comprehensive Psychiatry 56, 279-282, 2015 | 200 | 2015 |
Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap RS McIntyre, NL Rasgon, DE Kemp, HT Nguyen, CWY Law, VH Taylor, ... Current Diabetes Reports 9 (1), 51-59, 2009 | 155 | 2009 |
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders RS McIntyre, M Alsuwaidan, BI Goldstein, VH Taylor, A Schaffer, ... Ann Clin Psychiatry 24 (1), 69-81, 2012 | 149 | 2012 |
The psychological burden of the COVID-19 pandemic and associated lockdown measures: Experience from 4000 participants W Burhamah, A AlKhayyat, M Oroszlányová, A AlKenane, A Almansouri, ... Journal of affective disorders 277, 977-985, 2020 | 148 | 2020 |
Cracks and crevices: Globalization discourse and medical education BD Hodges, JM Maniate, MA Martimianakis, M Alsuwaidan, C Segouin Medical teacher 31 (10), 910-917, 2009 | 145 | 2009 |
The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the … RS McIntyre, JK Soczynska, DS Cha, HO Woldeyohannes, RS Dale, ... Journal of Affective Disorders 172, 259-264, 2015 | 135 | 2015 |
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications RS McIntyre, KY Park, CWY Law, F Sultan, A Adams, MT Lourenco, ... CNS drugs 24, 741-753, 2010 | 135 | 2010 |
The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders RS McIntyre, AM Powell, O Kaidanovich-Beilin, JK Soczynska, ... Behavioural brain research 237, 164-171, 2013 | 109 | 2013 |
Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? RS McIntyre, HA Kenna, HT Nguyen, CWY Law, F Sultan, ... Advances in therapy 27, 63-80, 2010 | 98 | 2010 |
The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project RS McIntyre, JK Soczynska, SS Liauw, HO Woldeyohannes, E Brietzke, ... The International Journal of Psychiatry in Medicine 43 (2), 165-177, 2012 | 91 | 2012 |
A preclinical and clinical rationale for quetiapine in mood syndromes RS McIntyre, JK Soczynska, HO Woldeyohannes, M Alsuwaidan, ... Expert Opinion on Pharmacotherapy 8 (9), 1211-1219, 2007 | 82 | 2007 |
Advancing biomarker research: utilizing ‘Big Data’approaches for the characterization and prevention of bipolar disorder RS McIntyre, DS Cha, JM Jerrell, W Swardfager, RD Kim, LG Costa, ... Bipolar disorders 16 (5), 531-547, 2014 | 77 | 2014 |
Aerobic physical exercise as a possible treatment for neurocognitive dysfunction in bipolar disorder A Kucyi, MT Alsuwaidan, SS Liauw, RS McIntyre Postgraduate medicine 122 (6), 107-116, 2010 | 74 | 2010 |
Exercise and bipolar disorder: a review of neurobiological mediators MT Alsuwaidan, A Kucyi, CWY Law, RS McIntyre Neuromolecular medicine 11, 328-336, 2009 | 72 | 2009 |
The hepatic safety profile of duloxetine: a review RS McIntyre, ZD Panjwani, HT Nguyen, HO Woldeyohannes, ... Expert opinion on drug metabolism & toxicology 4 (3), 281-285, 2008 | 64 | 2008 |
A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression JK Soczynska, SH Kennedy, M Alsuwaidan, RB Mansur, M Li, ... Bipolar disorders 19 (3), 198-213, 2017 | 60 | 2017 |